- Patent Title: Alkaline phosphatase agents for treatment of radiation disorders
-
Application No.: US16982211Application Date: 2019-03-20
-
Publication No.: US11654184B2Publication Date: 2023-05-23
- Inventor: Michael Kaleko , Christian Furlan Freguia , Sheila Connelly
- Applicant: Theriva Biologics, Inc.
- Applicant Address: US MD Rockville
- Assignee: Theriva Biologics, Inc.
- Current Assignee: Theriva Biologics, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/US2019/023143 2019.03.20
- International Announcement: WO2019/183209A 2019.09.26
- Date entered country: 2020-09-18
- Main IPC: A61K38/46
- IPC: A61K38/46 ; A61P39/00 ; A61K9/00
Abstract:
The present invention relates to, inter alia, compositions and methods, including therapeutic alkaline phosphatases that find use in the treatment or prevention of the effects of radiation exposure and/or chemotherapy.
Public/Granted literature
- US20210023182A1 ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF RADIATION DISORDERS Public/Granted day:2021-01-28
Information query
IPC分类:
